
Corporate M&A
Private Equity
Healthcare & Life Sciences
Technology
Emerging Companies & Venture Capital
Emily Cridland is a partner at Latham & Watkins in their London office, where she is a key member of the Corporate Department. With a focus on cross-border mergers and acquisitions, joint ventures, venture capital, and corporate reorganizations, Emily provides strategic legal counsel to clients across diverse industries. Her extensive experience includes working in-house on secondment to Markit Group Limited and serving on various committees within the firm. Emily holds a Bachelor of Law (Hons) from the University of Sussex and a Postgraduate Diploma in Legal Practice from Nottingham Law School. Her practice areas include Corporate M&A, Private Equity, and Healthcare & Life Sciences.
Healthcare and Life Sciences M&A
Technology and Telecommunications
Mining and Industrial
Media and Entertainment
- atai Life Sciences acted as the acquirer in this Strategic Investment transaction. - The acquisition targeted assets operating in the Biotechnology sector. - The transaction was announced on 04 Jan 2024 with a reported value of 3900000000.0.
Jan 04 2024
4B
M&A
Partner
2022 – Unknown
Associate
2012 – 2022
Trainee Solicitor
2010 – 2012
Secondee Legal Counsel
2015 – 2016
- Total Security Limited acted as the seller in this M&A transaction. - The divestment involved assets operating in the Marketing sector. - The transaction was announced on 05 Dec 2023 with a reported value of 3400000000.0.
Dec 05 2023
3B
M&A
Postgraduate Diploma in Legal Practice, Nottingham Law School
2010
Bachelor of Law (Hons), University of Sussex
2008